“A comprehensive toxicology program was conducted in both rats and cynomolgus monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 19Source ↗
Why that species
Monkey RAAS closely resembles human, making it pharmacologically relevant; rat is a low-potency responder species
“The cynomolgus monkey renin-angiotensin system closely resembles the human system, making it a relevant species for assessing pharmacodynamic efficacy and toxicity.”
✓ VerifiedFDA pharmacology/toxicology review, p. 19Source ↗
Surrogate molecule
No surrogate; the clinical compound was tested
“Baxdrostat was evaluated in repeat-dose oral toxicology studies of up to 6 months in rats and 9 months in monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 19Source ↗
Species: general tox
Rat and cynomolgus monkey
“A comprehensive toxicology program was conducted in both rats and cynomolgus monkeys.”
✓ VerifiedFDA pharmacology/toxicology review, p. 19Source ↗
Species: DART
Rat and rabbit (embryo-fetal development)
“While baxdrostat had no effects on embryo-fetal development in rats or rabbits dosed through organogenesis at exposures up to 54‑fold (rat) and 29-fold (rabbit) the human dose of 2 mg, baxdrostat showed greatly reduced potency in rats compared to humans, which limits the interpretability of the rodent data.”